Suppr超能文献

埃塞俄比亚耐多药结核病的患病率及相关因素:一项系统综述

Prevalence of Multidrug-Resistant Tuberculosis and Associated Factors in Ethiopia: A Systematic Review.

作者信息

Asgedom Solomon Weldegebreal, Teweldemedhin Mebrahtu, Gebreyesus Hailay

机构信息

School of Pharmacy, College of Health Sciences, Mekelle University, Mek'ele, Ethiopia.

Unit of Biomedical Science, School of Medicine, College of Health Sciences and Referral Hospital, Aksum University, Aksum, Ethiopia.

出版信息

J Pathog. 2018 Apr 3;2018:7104921. doi: 10.1155/2018/7104921. eCollection 2018.

Abstract

BACKGROUND

Multidrug-resistant tuberculosis (MDR-TB) has continued to be a challenge for tuberculosis (TB) control globally. Ethiopia is one of the countries with high MDR-TB burden.

OBJECTIVE

The main purpose of this study was to determine the prevalence of MDR-TB and associated factors in Ethiopia.

METHODS

A systematic review of the literatures on prevalence of MDR-TB and associated factors was conducted in the country.

RESULTS

In our electronic search, 546 citations were depicted. Among the total 546 citations described, a total of 22 articles met eligibility criteria and were included in the review article. According to our review, the prevalence of MDR-TB ranged from 0 to 46.3%. The average mean rate of MDR-TB in Ethiopia was found to be 12.6 ± 15.9%. The overall prevalence of MDR-TB in all TB cases was estimated to be 1.4%. From a total of 3849 patients studied, 527 had MDR-TB. Previous exposure to antituberculosis treatment was the most commonly identified risk factor of MDR-TB in Ethiopia.

CONCLUSION

Despite relative decline in incidence of MDR-TB, the distribution and prevalence of MDR-TB continued to be a serious challenge for TB control in Ethiopia. Previous exposure to antituberculosis treatment was also the most common risk factor for MDR-TB. Therefore, strong TB and MDR-TB treatment along with tight introduction of follow-up strategies should be applied for better TB control.

摘要

背景

耐多药结核病(MDR-TB)仍然是全球结核病控制面临的一项挑战。埃塞俄比亚是耐多药结核病负担较高的国家之一。

目的

本研究的主要目的是确定埃塞俄比亚耐多药结核病的患病率及其相关因素。

方法

对该国关于耐多药结核病患病率及其相关因素的文献进行系统综述。

结果

在我们的电子检索中,共找到546条引文。在所描述的546条引文中,共有22篇文章符合纳入标准并被纳入综述文章。根据我们的综述,耐多药结核病的患病率在0%至46.3%之间波动。埃塞俄比亚耐多药结核病的平均患病率为12.6±15.9%。所有结核病病例中耐多药结核病的总体患病率估计为1.4%。在总共3849名研究对象中,527人患有耐多药结核病。既往接受过抗结核治疗是埃塞俄比亚耐多药结核病最常见的危险因素。

结论

尽管耐多药结核病发病率有所下降,但耐多药结核病的分布和患病率仍然是埃塞俄比亚结核病控制面临的严峻挑战。既往接受过抗结核治疗也是耐多药结核病最常见的危险因素。因此,应加强结核病和耐多药结核病的治疗,并严格实施随访策略,以更好地控制结核病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0160/5903304/74950a5387fc/JPATH2018-7104921.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验